Krutz John Robert reported acquisition or exercise transactions in this Form 4 filing.
Calumet, Inc.’s Chief Accounting Officer John Robert Krutz reported two compensation-related equity awards in the form of restricted stock units. He received 931 Restricted Stock Units, each equal to one share of common stock, which are 100% vested and will be settled on a date he specifies or upon his termination.
He also received 310 Restricted Stock Units that will be settled under the company’s Deferred Compensation Plan on the earlier of a specified date or his termination, with 25% of these units vesting on July 1 of each year beginning on July 1, 2027.
Adams Asset Advisors, LLC filed an Amendment No. 2 to a Schedule 13G/A reporting beneficial ownership of 4,061,388 shares of Calumet, Inc. Common Stock, representing 4.68% of the class.
The filing lists 2,809,156 shares as sole voting power and 1,252,232 as shared voting power. The filing is signed by Steven Adams as Owner.
The Vanguard Group filed an amendment to Schedule 13G/A reporting 0 shares of Calumet Inc. The amendment notes an internal realignment on January 12, 2026 and explains that certain subsidiaries/business divisions will report beneficial ownership separately in reliance on SEC Release No. 34-39538 (January 12, 1998). The filing is signed on 03/26/2026 and shows no sole or shared voting or dispositive power over Calumet common stock.
Calumet, Inc. reported that board member Jennifer G. Straumins has decided not to stand for re-election and will retire from the Board at the end of her current term, which expires at the Company’s 2026 Annual Meeting of Stockholders.
The Company stated that her decision is not due to any disagreement with its operations, policies, or practices. Calumet issued a press release with additional background on her long association with the business and noted that the Board, through its Nominating and Governance Committee, will continue evaluating Board composition and skills to align with the Company’s strategy and governance practices.
Calumet, Inc. has completed a private placement of $150 million in additional 9.75% Senior Notes due 2031 through its subsidiaries Calumet Specialty Products Partners, L.P. and Calumet Finance Corp. The notes were sold at 105% of par, generating net proceeds of approximately $154.9 million.
The company intends to use these proceeds to repay borrowings outstanding under its revolving credit facility, effectively terming out a portion of its short-term debt into longer-dated senior notes. These Additional Notes form a single series with the existing $405 million of 9.75% Senior Notes due 2031, sharing the same terms other than initial offering price.
Calumet, Inc. announced that its subsidiaries agreed to sell $150 million aggregate principal amount of 9.75% Senior Notes due 2031 in a private offering under Rule 144A and Regulation S. The notes will be issued at 105% of par, generating approximately $154.9 million in net proceeds, which Calumet plans to use to repay borrowings under its revolving credit facility.
The new notes are an additional issuance to the existing $405 million of 9.75% Senior Notes due 2031, forming a single series with the same terms other than initial offering price. Calumet also executed a Tenth Amendment to its Third Amended and Restated Credit Agreement to permit this new indebtedness.
Calumet, Inc. has announced that its subsidiaries intend to privately issue $150 million of 9.75% Senior Notes due 2031 as a tack-on to existing notes. The new notes will form a single series with $405 million of the same 9.75% Senior Notes issued on January 12, 2026.
The company plans to use the net proceeds to repay borrowings under its revolving credit facility, effectively refinancing debt. The offering will be made to eligible purchasers under Rule 144A and Regulation S and the notes will not be registered under the Securities Act.
Calumet, Inc. EVP – Specialties Scott Obermeier exercised 24,090 restricted stock units into common shares on March 9, 2026. Each unit was economically equivalent to one share of common stock. To satisfy tax withholding liabilities, he surrendered 10,584 common shares to the company rather than selling them in the market. After these compensation-related transactions, he directly owned 237,656 shares of Calumet common stock.
Calumet, Inc. (CLMT) senior vice president and general counsel Gregory J. Morical exercised vested restricted stock units and settled related taxes in shares. On March 9, 2026, he converted 15,348 Restricted Stock Units into 15,348 shares of common stock at an exercise price of $0.00 per share.
Footnotes state that each Restricted Stock Unit equaled one share of common stock and that 100% of the units vested on February 21, 2026. To cover tax withholding obligations under Rule 16b-3, he surrendered 6,952 shares of common stock back to the issuer. After these transactions, he directly owned 47,811 shares of Calumet, Inc. common stock. This pattern reflects routine equity compensation vesting, with part of the award used to satisfy taxes rather than an open-market sale.